Drug Type Small molecule drug |
Synonyms QTX-153 |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | Spain | 01 Dec 2025 | |
| Charcot-Marie-Tooth Disease | Preclinical | Spain | 01 Dec 2025 | |
| Obesity | Preclinical | Spain | 01 Dec 2025 | |
| Rett Syndrome | Preclinical | Spain | 01 Dec 2025 |





